Product Code: SR1423A115_Report
The global patient centric healthcare app market size reached US$ 10.4 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 32.4 Billion by 2028, exhibiting a growth rate (CAGR) of 20.5% during 2023-2028.
A patient centric healthcare application (app) offers health-related services conveniently from a device, such as a smartphone and tablet. It is utilized by patients to monitor numerous aspects of their health, including weight, calorie count, blood glucose measurements, dehydration levels, and physical activity. It aids in managing chronic diseases like diabetes and hypertension and facilitating electronic data interchange (EDI) with clinicians. At present, there is a significant rise in the utilization of telehealth/telemedicine on account of the coronavirus disease (COVID-19) outbreak. As a result, the demand for patient centric healthcare app is rising across the globe.
Patient Centric Healthcare App Market Trends:
- Nowadays, mobile app developers are collaborating with healthcare experts to offer patient centric healthcare apps, which can work without an internet connection to support uninterrupted access. This, in confluence with the increasing reliance on smartphones and other devices for disease monitoring, represents one of the key factors driving the market. Moreover, patient centric healthcare apps help in addressing smoking cessation and keeping track of nutritional intake and vaccinations. They also enable practitioners ensure that treatments recognize the needs and preferences of a patient. As a result, these apps are increasingly being used by individuals with cancer to log medications, track treatment progress, monitor side effects, and schedule follow-up appointments. Besides this, advances in information technology (IT) have introduced new design approaches that comprise healthcare delivery and patient education. This, coupled with the increasing adoption of wearable devices, which help monitor heart rate, tremors, posture control, and sleep patterns, is offering lucrative growth opportunities to market players. Other factors, such as the increasing geriatric population and the rising health consciousness among individuals, are driving the market.
Key Market Segmentation:
- IMARC Group provides an analysis of the key trends in each sub-segment of the global patient centric healthcare app market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on technology, operating system, application and end user.
Breakup by Technology:
- Phone-Based Apps
- Web-Based Apps
- Wearable Patient Centric Apps
Breakup by Operating System:
- iOS
- Android
- Windows
- Others
Breakup by Application:
- Wellness Management
- Disease and Treatment Management
Breakup by End User:
- Hospitals
- Clinics
- Home Use
Breakup by Region:
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
Competitive Landscape:
- The competitive landscape of the industry has also been examined along with the profiles of the key players being Allscripts Healthcare Solutions Inc., Athenahealth Inc., Bayer Aktiengesellschaft, Boston Scientific Corporation, Hill-Rom Services Inc. (Baxter International Inc.), iPatientCare LLC, Koninklijke Philips N.V., Merck & Co. Inc., Mobilesmith Inc., Pfizer Inc. and Siemens Healthineers AG (Siemens AG).
Key Questions Answered in This Report:
- How has the global patient centric healthcare app market performed so far and how will it perform in the coming years?
- What has been the impact of COVID-19 on the global patient centric healthcare app market?
- What are the key regional markets?
- What is the breakup of the market based on the technology?
- What is the breakup of the market based on the operating system?
- What is the breakup of the market based on the application?
- What is the breakup of the market based on the end user?
- What are the various stages in the value chain of the industry?
- What are the key driving factors and challenges in the industry?
- What is the structure of the global patient centric healthcare app market and who are the key players?
- What is the degree of competition in the industry?
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Patient Centric Healthcare App Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Technology
- 6.1 Phone-Based Apps
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
- 6.2 Web-Based Apps
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
- 6.3 Wearable Patient Centric Apps
- 6.3.1 Market Trends
- 6.3.2 Market Forecast
7 Market Breakup by Operating System
- 7.1 iOS
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Android
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
- 7.3 Windows
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
- 7.4 Others
- 7.4.1 Market Trends
- 7.4.2 Market Forecast
8 Market Breakup by Application
- 8.1 Wellness Management
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
- 8.2 Disease and Treatment Management
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
9 Market Breakup by End User
- 9.1 Hospitals
- 9.1.1 Market Trends
- 9.1.2 Market Forecast
- 9.2 Clinics
- 9.2.1 Market Trends
- 9.2.2 Market Forecast
- 9.3 Home Use
- 9.3.1 Market Trends
- 9.3.2 Market Forecast
10 Market Breakup by Region
- 10.1 North America
- 10.1.1 United States
- 10.1.1.1 Market Trends
- 10.1.1.2 Market Forecast
- 10.1.2 Canada
- 10.1.2.1 Market Trends
- 10.1.2.2 Market Forecast
- 10.2 Asia-Pacific
- 10.2.1 China
- 10.2.1.1 Market Trends
- 10.2.1.2 Market Forecast
- 10.2.2 Japan
- 10.2.2.1 Market Trends
- 10.2.2.2 Market Forecast
- 10.2.3 India
- 10.2.3.1 Market Trends
- 10.2.3.2 Market Forecast
- 10.2.4 South Korea
- 10.2.4.1 Market Trends
- 10.2.4.2 Market Forecast
- 10.2.5 Australia
- 10.2.5.1 Market Trends
- 10.2.5.2 Market Forecast
- 10.2.6 Indonesia
- 10.2.6.1 Market Trends
- 10.2.6.2 Market Forecast
- 10.2.7 Others
- 10.2.7.1 Market Trends
- 10.2.7.2 Market Forecast
- 10.3 Europe
- 10.3.1 Germany
- 10.3.1.1 Market Trends
- 10.3.1.2 Market Forecast
- 10.3.2 France
- 10.3.2.1 Market Trends
- 10.3.2.2 Market Forecast
- 10.3.3 United Kingdom
- 10.3.3.1 Market Trends
- 10.3.3.2 Market Forecast
- 10.3.4 Italy
- 10.3.4.1 Market Trends
- 10.3.4.2 Market Forecast
- 10.3.5 Spain
- 10.3.5.1 Market Trends
- 10.3.5.2 Market Forecast
- 10.3.6 Russia
- 10.3.6.1 Market Trends
- 10.3.6.2 Market Forecast
- 10.3.7 Others
- 10.3.7.1 Market Trends
- 10.3.7.2 Market Forecast
- 10.4 Latin America
- 10.4.1 Brazil
- 10.4.1.1 Market Trends
- 10.4.1.2 Market Forecast
- 10.4.2 Mexico
- 10.4.2.1 Market Trends
- 10.4.2.2 Market Forecast
- 10.4.3 Others
- 10.4.3.1 Market Trends
- 10.4.3.2 Market Forecast
- 10.5 Middle East and Africa
- 10.5.1 Market Trends
- 10.5.2 Market Breakup by Country
- 10.5.3 Market Forecast
11 SWOT Analysis
- 11.1 Overview
- 11.2 Strengths
- 11.3 Weaknesses
- 11.4 Opportunities
- 11.5 Threats
12 Value Chain Analysis
13 Porters Five Forces Analysis
- 13.1 Overview
- 13.2 Bargaining Power of Buyers
- 13.3 Bargaining Power of Suppliers
- 13.4 Degree of Competition
- 13.5 Threat of New Entrants
- 13.6 Threat of Substitutes
14 Price Analysis
15 Competitive Landscape
- 15.1 Market Structure
- 15.2 Key Players
- 15.3 Profiles of Key Players
- 15.3.1 Allscripts Healthcare Solutions Inc.
- 15.3.1.1 Company Overview
- 15.3.1.2 Product Portfolio
- 15.3.1.3 Financials
- 15.3.1.4 SWOT Analysis
- 15.3.2 Athenahealth Inc.
- 15.3.2.1 Company Overview
- 15.3.2.2 Product Portfolio
- 15.3.3 Bayer Aktiengesellschaft
- 15.3.3.1 Company Overview
- 15.3.3.2 Product Portfolio
- 15.3.3.3 Financials
- 15.3.3.4 SWOT Analysis
- 15.3.4 Boston Scientific Corporation
- 15.3.4.1 Company Overview
- 15.3.4.2 Product Portfolio
- 15.3.4.3 Financials
- 15.3.4.4 SWOT Analysis
- 15.3.5 Hill-Rom Services Inc. (Baxter International Inc.)
- 15.3.5.1 Company Overview
- 15.3.5.2 Product Portfolio
- 15.3.5.3 SWOT Analysis
- 15.3.6 iPatientCare LLC
- 15.3.6.1 Company Overview
- 15.3.6.2 Product Portfolio
- 15.3.7 Koninklijke Philips N.V.
- 15.3.7.1 Company Overview
- 15.3.7.2 Product Portfolio
- 15.3.7.3 Financials
- 15.3.7.4 SWOT Analysis
- 15.3.8 Merck & Co. Inc.
- 15.3.8.1 Company Overview
- 15.3.8.2 Product Portfolio
- 15.3.8.3 Financials
- 15.3.8.4 SWOT Analysis
- 15.3.9 Mobilesmith Inc.
- 15.3.9.1 Company Overview
- 15.3.9.2 Product Portfolio
- 15.3.9.3 Financials
- 15.3.10 Pfizer Inc.
- 15.3.10.1 Company Overview
- 15.3.10.2 Product Portfolio
- 15.3.10.3 Financials
- 15.3.10.4 SWOT Analysis
- 15.3.11 Siemens Healthineers AG (Siemens AG)
- 15.3.11.1 Company Overview
- 15.3.11.2 Product Portfolio
- 15.3.11.3 Financials
- 15.3.11.4 SWOT Analysis